F G Spinale

Author PubWeight™ 93.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of neuromuscular blockade on mask ventilation. Anaesthesia 2011 2.88
2 Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998 2.77
3 Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 1998 1.96
4 Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001 1.81
5 Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 2001 1.59
6 Retrograde versus antegrade cardioplegia: impact on right ventricular function. Ann Thorac Surg 1992 1.38
7 Use of a combined right ventricular ejection fraction-oximetry catheter system for coronary bypass surgery. Crit Care Med 1992 1.38
8 Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest 1994 1.24
9 Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function. Circulation 1991 1.18
10 Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. Am J Physiol Heart Circ Physiol 2001 1.17
11 Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. Circulation 1998 1.14
12 Myocardial matrix metalloproteinase activity and abundance with congestive heart failure. Am J Physiol 1998 1.13
13 Differential effects of calcium channel antagonists in the amelioration of radial artery vasospasm. Ann Thorac Surg 2000 1.13
14 L-type calcium channel abundance and function with cardiac hypertrophy and failure: a review. J Mol Cell Cardiol 1998 1.10
15 Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation. Am J Physiol Heart Circ Physiol 2001 1.09
16 Magnesium supplementation in the prevention of arrhythmias in pediatric patients undergoing surgery for congenital heart defects. Am Heart J 2000 1.07
17 Inhibition of collagen cross-linking: effects on fibrillar collagen and ventricular diastolic function. Am J Physiol 1995 1.07
18 Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control. Am J Physiol Heart Circ Physiol 2000 1.06
19 Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice. J Mol Cell Cardiol 2000 1.06
20 Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations. Am J Physiol 1999 1.05
21 Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases. Ann Thorac Surg 2001 1.05
22 Endothelin-1 during and after cardiopulmonary bypass: association to graft sensitivity and postoperative recovery. J Thorac Cardiovasc Surg 2001 0.99
23 Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Circ Res 1991 0.96
24 The direct effects of 3,5,3'-triiodo-L-thyronine (T3) on myocyte contractile processes. Insights into mechanisms of action. J Thorac Cardiovasc Surg 1995 0.95
25 The structure and function of the cardiac myocyte: a review of fundamental concepts. J Thorac Cardiovasc Surg 1999 0.94
26 Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction. Circulation 2000 0.94
27 Relationship between external load and isolated myocyte contractile function with CHF in pigs. Am J Physiol 1997 0.92
28 Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry. J Pharmacol Exp Ther 1999 0.92
29 DAPI as a useful stain for nuclear quantitation. Biotech Histochem 1991 0.91
30 Temporal endothelin dynamics of the myocardial interstitium and systemic circulation in cardiopulmonary bypass. J Thorac Cardiovasc Surg 2000 0.91
31 Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2001 0.91
32 Cell and sarcomere contractile performance from the same cardiocyte using video microscopy. J Appl Physiol (1985) 1993 0.90
33 Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium. Ann Med 2001 0.90
34 Comparison of three blood-processing techniques during and after cardiopulmonary bypass. Ann Thorac Surg 1993 0.89
35 Temporal synthesis and release of endothelin within the systemic and myocardial circulation during and after cardiopulmonary bypass: relation to postoperative recovery. J Cardiothorac Vasc Anesth 2000 0.89
36 Tranexamic acid reduces bleeding after cardiopulmonary bypass when compared to epsilon aminocaproic acid and placebo. J Card Surg 1998 0.88
37 Sedative and cardiovascular effects of midazolam in swine. Lab Anim Sci 1991 0.87
38 Potassium channel opener-augmented cardioplegia: protection of myocyte contractility with chronic left ventricular dysfunction. Circulation 1997 0.87
39 Brain blood flow patterns after the development of congestive heart failure: effects of treadmill exercise. Crit Care Med 2000 0.86
40 Bioimpedance: a novel method for the determination of extravascular lung water. J Surg Res 1990 0.86
41 Effect of chronic supraventricular tachycardia on left ventricular function and structure in newborn pigs. J Am Coll Cardiol 1992 0.86
42 Potential role of endothelin receptor antagonists in the setting of cardiopulmonary bypass: relevance to myocardial performance. Heart Fail Rev 2001 0.86
43 Spatial characterization of contracting cardiac myocytes by computer-assisted, video-based image processing. Am J Physiol 1996 0.85
44 Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns. Cardiovasc Res 1998 0.85
45 Right and left ventricular geometry and myocyte contractile processes with dilated cardiomyopathy: myocyte growth and beta-adrenergic responsiveness. Cardiovasc Res 1996 0.84
46 Isolated left ventricular myocyte contractility in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1998 0.84
47 The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. J Mol Cell Cardiol 1993 0.84
48 Amlodipine monotherapy, angiotensin-converting enzyme inhibition, and combination therapy with pacing-induced heart failure. Hypertension 1998 0.84
49 Effects of combined angiotensin II and endothelin receptor blockade with developing heart failure: effects on left ventricular performance. Circulation 2000 0.83
50 ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression. Am J Physiol Heart Circ Physiol 2000 0.83
51 Changes in L-type calcium channel abundance and function during the transition to pacing-induced congestive heart failure. Cardiovasc Res 1998 0.83
52 Contractile and cytoskeletal content, structure, and mRNA levels with tachycardia-induced cardiomyopathy. Am J Physiol 1995 0.83
53 Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol 1996 0.83
54 Negative and selective effects of propofol on isolated swine myocyte contractile function in pacing-induced congestive heart failure. Anesthesiology 1997 0.82
55 Direct effects of protamine sulfate on myocyte contractile processes. Cellular and molecular mechanisms. Circulation 1995 0.82
56 Direct effects of oxygenated crystalloid or blood cardioplegia on isolated myocyte contractile function. J Thorac Cardiovasc Surg 1996 0.81
57 Blood damaging effects in cardiotomy suction return. 1988. J Extra Corpor Technol 2012 0.81
58 Contributory role of matrix metalloproteinases in cardiovascular remodeling. Curr Drug Targets Cardiovasc Haematol Disord 2001 0.81
59 Cardiocyte contractile performance in experimental biventricular volume-overload hypertrophy. Am J Physiol 1993 0.81
60 Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure. J Am Coll Cardiol 1996 0.81
61 Immunocytochemical and enzyme histochemical localization of Na+,K(+)-ATPase in normal and ischemic porcine myocardium. J Mol Cell Cardiol 1990 0.81
62 Treatment with a growth hormone secretagogue in a model of developing heart failure: effects on ventricular and myocyte function. Circulation 2001 0.80
63 Myocyte endothelin exposure during cardioplegic arrest exacerbates contractile dysfunction after reperfusion. Anesth Analg 2000 0.80
64 ATP-sensitive potassium channel activation before cardioplegia. Effects on ventricular and myocyte function. Circulation 1998 0.79
65 beta-Adrenergic and endothelin receptor interaction in dilated human cardiomyopathic myocardium. J Card Fail 2001 0.79
66 Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure. Circulation 1999 0.79
67 Technical aspects of cardiac catheterization of swine. J Invest Surg 1989 0.79
68 Heritable ventricular septal defect in Yucatan miniature swine. Lab Anim Sci 1990 0.79
69 Preservation of myocyte contractile function after hyperthermic cardioplegic arrest by activation of ATP-sensitive potassium channels. Circulation 1997 0.79
70 The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilated cardiomyopathy. J Thorac Cardiovasc Surg 1994 0.79
71 Protamine use during peripheral vascular surgery: a prospective randomized trial. J Vasc Surg 1995 0.79
72 Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure. J Pharmacol Exp Ther 2000 0.78
73 Effect of pulmonary resection on right ventricular function. Ann Thorac Surg 1992 0.78
74 Direct effects of acute administration of 3, 5, 3' triiodo-L-thyronine on myocyte function. Ann Thorac Surg 1994 0.78
75 AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns. J Card Fail 1998 0.78
76 Mechanisms of right ventricular dysfunction after pulmonary resection. Ann Thorac Surg 1996 0.78
77 Controlling myocardial matrix remodeling: implications for heart failure. Cardiol Rev 1999 0.78
78 Effects of adenosine receptor subtype A1 on ventricular and renal function. J Cardiovasc Pharmacol 2001 0.78
79 Expression and activity of pulmonary endothelin converting enzyme in heart failure: relation to endothelin biosynthesis and receptor distribution. J Card Fail 2001 0.78
80 Left ventricular regional myocyte contractility in normal and heart failure states. J Mol Cell Cardiol 1997 0.77
81 Preservation of myocyte contractile function after hypothermic, hyperkalemic cardioplegic arrest with 2, 3-butanedione monoxime. J Thorac Cardiovasc Surg 1996 0.77
82 Defects in matrix metalloproteinase inhibitory stoichiometry and selective MMP induction in patients with nonischemic or ischemic dilated cardiomyopathy. Ann N Y Acad Sci 1999 0.77
83 The pig as a model of tachycardia and dilated cardiomyopathy. Lab Anim Sci 1990 0.77
84 The relation between changes in myocyte orientation and contractile function with electrical field stimulation. Basic Res Cardiol 1997 0.77
85 Protein kinase C activation before cardioplegic arrest: beneficial effects on myocyte contractility. J Thorac Cardiovasc Surg 1997 0.77
86 Myosin heavy chain synthesis is increased in a rabbit model of heart failure. Am J Physiol 1997 0.77
87 The direct effects of propofol on myocyte contractile function after hypothermic cardioplegic arrest. Anesth Analg 1996 0.77
88 Identification of patients at risk for excessive blood loss during coronary artery bypass surgery: thromboelastography versus coagulation screen. Anesth Analg 1993 0.77
89 Endothelin receptor pathway in human left ventricular myocytes: relation to contractility. Ann Thorac Surg 2000 0.77
90 Assessment of right ventricular contractile performance after pulmonary resection. Ann Thorac Surg 1993 0.76
91 Cardiopulmonary bypass in a gravid patient: perioperative changes in endothelin levels. Ann Thorac Surg 1998 0.76
92 Angiotensin AT1 receptor inhibition in pacing induced heart failure: effects on left ventricular myocardial collagen content and composition. J Mol Cell Cardiol 1998 0.76
93 Effects of cardiomyoplasty on biventricular function in canine chronic heart failure. Ann Thorac Surg 1993 0.76
94 Cardiac function and morphology of Hanford miniature swine and Yucatan miniature and micro swine. Lab Anim Sci 1990 0.76
95 Direct effects of thrombin on myocyte contractile function. Ann Thorac Surg 1995 0.76
96 Myocyte contractile responsiveness after hypothermic, hyperkalemic cardioplegic arrest. Disparity between exogenous calcium and beta-adrenergic stimulation. Anesthesiology 1995 0.76
97 Myosin heavy chain synthesis during the progression of chronic tachycardia induced heart failure in rabbits. Basic Res Cardiol 1998 0.76
98 Selective upregulation of endothelin converting enzyme-1a in the human failing heart. J Card Fail 2000 0.76
99 Effects of chronic tachycardia-induced cardiomyopathy on the beta-adrenergic receptor system. J Thorac Cardiovasc Surg 1992 0.76
100 Myocyte electrophysiological properties following the development of supraventricular tachycardia-induced cardiomyopathy. J Mol Cell Cardiol 1995 0.75
101 Effects of chronic supraventricular pacing tachycardia on relaxation rate in isolated cardiac muscle cells. Am J Physiol 1995 0.75
102 The use of positive end expiratory pressure to alter systemic-pulmonary shunt flow using conventional and high frequency jet ventilators. Curr Surg 1988 0.75
103 Differential effects of protamine sulfate on myocyte contractile function with left ventricular failure. J Am Coll Cardiol 1995 0.75
104 The acute effects of flecainide in the swine heart failing from incessant supraventricular tachycardia. Am Heart J 1991 0.75
105 Normothermic versus hypothermic hyperkalemic cardioplegia: effects on myocyte contractility. Ann Thorac Surg 1998 0.75
106 Effects of protamine on myocyte contractile function and beta-adrenergic responsiveness. Ann Thorac Surg 1994 0.75
107 Pretreatment with 3,5,3'triiodo-L-thyronine (T3). Effects on myocyte contractile function after hypothermic cardioplegic arrest and rewarming. J Thorac Cardiovasc Surg 1995 0.75
108 Effects of angiotensin type-I receptor blockade on pericardial fibrosis. J Surg Res 1999 0.75
109 Beneficial effects of myocyte preconditioning on contractile processes after cardioplegic arrest. Ann Thorac Surg 1996 0.75
110 In vitro validation of a right ventricular thermodilution ejection fraction system. Ann Biomed Eng 1991 0.75
111 Examination of epimysial leads used to stimulate the latissimus dorsi muscle. IEEE Trans Biomed Eng 1996 0.75
112 The direct and interactive effects of phosphodiesterase inhibition and beta-adrenergic stimulation on myocyte contractile function after hypothermic cardioplegic arrest. Anesth Analg 1995 0.75
113 The effect of basic fibroblast growth factor on the blood flow and morphologic features of a latissimus dorsi cardiomyoplasty. J Thorac Cardiovasc Surg 1996 0.75
114 Hypothermic potassium cardioplegia impairs myocyte recovery of contractility and inotropy. J Thorac Cardiovasc Surg 1994 0.75
115 Inducible lethal ventricular arrhythmias in swine with pacing-induced heart failure. Basic Res Cardiol 1999 0.75
116 Myocardial electrophysiological properties in the presence of an AT1 angiotensin II receptor antagonist. Basic Res Cardiol 1997 0.75
117 Myocardial effects of repetitive episodes of rapid ventricular pacing in conscious dogs: surgical creation, echocardiographic evaluation, and morphometric analysis. Lab Anim Sci 1994 0.75
118 Temporal relation of ATP-sensitive potassium-channel activation and contractility before cardioplegia. Ann Thorac Surg 1998 0.75
119 Novel approaches to retard ventricular remodeling in heart failure. Eur J Heart Fail 1999 0.75
120 Anesthetic and postoperative protocols for a canine model of reversible left ventricular volume overload. J Invest Surg 1991 0.75
121 Comparison of amlodipine or nifedipine treatment with developing congestive heart failure: effects on myocyte contractility. J Card Fail 2001 0.75
122 Differential effects of novel protamine variants on myocyte contractile function with left ventricular failure. Surgery 1997 0.75
123 Long-term angiotensin-converting enzyme and angiotensin I--receptor inhibition in pacing-induced heart failure: effects on myocardial interstitial bradykinin levels. J Card Fail 2001 0.75
124 The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure. J Am Coll Cardiol 1998 0.75
125 Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs. J Cardiovasc Pharmacol 1998 0.75
126 Pulmonary hemodynamics and endothelin levels in pacing-induced heart failure: during rest and exercise. J Card Fail 1997 0.75
127 Myocardial bradykinin following acute angiotensin-converting enzyme inhibition, AT1 receptor blockade, or combined inhibition in congestive heart failure. J Cardiovasc Pharmacol Ther 2001 0.75
128 3,5,3' Triiodo-L-thyronine pretreatment with cardioplegic arrest and chronic left ventricular dysfunction. Ann Thorac Surg 1995 0.75
129 Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise. Am J Cardiol 1999 0.75
130 Right ventricular pump dysfunction with acute experimental septic shock. J Surg Res 1991 0.75
131 The identification of contributory mechanisms for the development and progression of congestive heart failure in animal models. J Heart Lung Transplant 1996 0.75
132 The relation between latissimus dorsi skeletal muscle structure and contractile function after cardiomyoplasty. J Thorac Cardiovasc Surg 1994 0.75
133 Direct and interactive effects of cardioplegic arrest and protamine on myocyte contractility. Ann Thorac Surg 1996 0.75
134 Contributory mechanisms for the beneficial effects of myocyte preconditioning during cardioplegic arrest. Circulation 1996 0.75
135 Fate of gelatin-resorcinol-formaldehyde/glutaraldeyde adhesive on femoral vessel morphology. J Surg Res 1997 0.75
136 Supernormal ejection performance is isolated to the ipsilateral congenitally pressure-overloaded ventricle. J Am Coll Cardiol 1989 0.75
137 Bradykinin degradation and relation to myocyte contractility. J Cardiovasc Pharmacol Ther 2000 0.75
138 Myocyte contractile dysfunction with hypertrophy and failure: relevance to cardiac surgery. J Thorac Cardiovasc Surg 2000 0.75
139 Protective effects of adenosine on myocyte contractility during cardioplegic arrest. Ann Thorac Surg 1997 0.75
140 Developmental differences in myocyte contractile response after cardioplegic arrest. J Thorac Cardiovasc Surg 1996 0.75
141 Effects of chronic angiotensin-converting enzyme inhibition on left ventricular and myocyte structure and function during recovery from chronic rapid pacing. J Mol Cell Cardiol 1997 0.75
142 The direct effects of protamine sulfate on myocyte contractile processes. J Thorac Cardiovasc Surg 1994 0.75
143 Downstream defects in beta-adrenergic signaling and relation to myocyte contractility after cardioplegic arrest. J Thorac Cardiovasc Surg 1998 0.75